A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease.
Kutlar A, Ataga K, Reid M, Vichinsky EP, Neumayr L, Blair-Britt L, Labotka R, Glass J, Keefer JR, Wargin WA, Berenson R, Perrine SP.
Kutlar A, et al. Among authors: wargin wa.
Am J Hematol. 2012 Nov;87(11):1017-21. doi: 10.1002/ajh.23306. Epub 2012 Aug 7.
Am J Hematol. 2012.
PMID: 22887019
Free PMC article.
Clinical Trial.